Details for New Drug Application (NDA): 020864
✉ Email this page to a colleague
The generic ingredient in MAXALT is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 020864
Tradename: | MAXALT |
Applicant: | Organon Llc |
Ingredient: | rizatriptan benzoate |
Patents: | 0 |
Pharmacology for NDA: 020864
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 020864
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MAXALT | rizatriptan benzoate | TABLET;ORAL | 020864 | NDA | Organon LLC | 78206-142 | 78206-142-01 | 18 POUCH in 1 CARTON (78206-142-01) / 1 TABLET in 1 POUCH (78206-142-99) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jun 29, 1998 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jun 29, 1998 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020864
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Llc | MAXALT | rizatriptan benzoate | TABLET;ORAL | 020864-002 | Jun 29, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Organon Llc | MAXALT | rizatriptan benzoate | TABLET;ORAL | 020864-001 | Jun 29, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Organon Llc | MAXALT | rizatriptan benzoate | TABLET;ORAL | 020864-002 | Jun 29, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Organon Llc | MAXALT | rizatriptan benzoate | TABLET;ORAL | 020864-001 | Jun 29, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription